Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

PhiSkin Raises $17 Million for China Aesthetic Clinics

publication date: Jun 6, 2017
PhiSkin, a Shanghai aesthetic medical provider, raised $17 million in a Series B round, led by Legend Capital of China and joined by Ares Management, a Los Angeles alternative asset manager. Founded in 2012, PhiSkin offers minimally invasive treatments that include injection of aesthetic products, laser treatment, double eyelid surgery and other non-surgical beauty treatments. The company already has clinics and beauty centers in Shanghai, Beijing, Ningbo and Hangzhou, with plans to expand to 10 centers by the end of 2017 and 38 by 2019. More details....

Share this with colleagues:  


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital